Cargando…

P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS

Detalles Bibliográficos
Autores principales:	Shortt, Jake, Feldman, Tatyana, Collins, Graham, Zain, Jasmine, Khot, Amit, Seok Kim, Jin, Morschhauser, Franck, Min Kim, Tae, Roderick, Justine, Lim Yoon, Jeong, Sharma, Shringi, Saeh, Jamal, Dai, Jiale, Reyes, Ruben, Olsson, Richardp, Luigi Zinzani, Pier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431056/ http://dx.doi.org/10.1097/01.HS9.0000971460.41693.c0

Ejemplares similares

P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
por: Strati, Paolo, et al.
Publicado: (2023)

P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY
por: Kim, Won-Seog, et al.
Publicado: (2023)

PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
por: Shortt, Jake, et al.
Publicado: (2023)

4573 Characterization of vascular disease in an Acta2 mutant mouse model
por: Kaw, Anita, et al.
Publicado: (2020)

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
por: Aubrais, Raphaelle, et al.
Publicado: (2022)

M11.4.1: Electron beam emittance meter finished
por: CORDE, S, et al.
Publicado: (2011)

Editorial: PTCL from genes to therapy
por: Janikova, Andrea
Publicado: (2022)

P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1
por: van de Donk, Niels W.C.J., et al.
Publicado: (2023)

D11.4.1: Preliminary electron beam emittance measurement report
por: THAURY, C, et al.
Publicado: (2012)

Abbreviated breast MRI for screening women with dense breast: the EA1141 trial
por: Kuhl, Christiane K
Publicado: (2018)

1141. Incidence of adolescent syncope and related injuries following vaccination and routine venipuncture
por: Groom, Holly C, et al.
Publicado: (2023)

Role of stem cell transplant in CD30(+) PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
por: Savage, Kerry J., et al.
Publicado: (2022)

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY
por: Opat, S., et al.
Publicado: (2022)

1141. Implementation of a Pediatric Handshake Antimicrobial Stewardship Program to Improve Antimicrobial Utilization
por: Hughes, Amanda P, et al.
Publicado: (2019)

An Auditory BCI System for Assisting CRS-R Behavioral Assessment in Patients with Disorders of Consciousness
por: Xiao, Jun, et al.
Publicado: (2016)

PTCL, NOS: An update on classification, risk-stratification, and treatment
por: Weiss, Jonathan, et al.
Publicado: (2023)

1141. Composition of Placental Cultures and Correlation with Maternal and Infant Blood Cultures in Mothers with Suspected Chorioamnionitis
por: Gordon, Laurel, et al.
Publicado: (2020)

Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS
por: Cutucache, Christine E., et al.
Publicado: (2016)

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
por: Lu, Guang, et al.
Publicado: (2023)

The influence of the CRS-R score on functional outcome in patients with severe brain injury receiving early rehabilitation
por: Boltzmann, Melanie, et al.
Publicado: (2021)

Permanent Draft Genome Sequence of Rhizobium sp. Strain LCM 4573, a Salt-Tolerant, Nitrogen-Fixing Bacterium Isolated from Senegalese Soils
por: Diagne, Nathalie, et al.
Publicado: (2017)

How molecular advances may improve the diagnosis and management of PTCL patients
por: Drieux, Fanny, et al.
Publicado: (2023)

P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL
por: Opat, Stephen, et al.
Publicado: (2023)

1141. Microbial Assessment of Healthcare-Associated Pathogens on Various Environmental Sites in Patient Rooms After Terminal Room Disinfection
por: Kanamori, Hajime, et al.
Publicado: (2018)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021)

Selection strategies to introgress water deficit tolerance derived from Solanum galapagense accession LA1141 into cultivated tomato
por: Fenstemaker, Sean, et al.
Publicado: (2022)

Genome Sequence of Pseudomonas koreensis CRS05-R5, an Antagonistic Bacterium Isolated from Rice Paddy Field
por: Lin, Haiyan, et al.
Publicado: (2016)

P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST-IN-HUMAN STUDY
por: Desai, Pinkal, et al.
Publicado: (2023)

P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL
por: Marconi, Giovanni, et al.
Publicado: (2023)

Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification
por: Miyawaki, Kohta, et al.
Publicado: (2022)

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum
por: Gaigalat, Lars, et al.
Publicado: (2007)

Immune system elements - a puzzle in CRS
por: Kowalik, Katarzyna, et al.
Publicado: (2022)

P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY
por: Tivey, A., et al.
Publicado: (2022)

The Italian scenario, pts 1-2
por: Belloni, L
Publicado: (1987)

PTS: a pharmaceutical target seeker
por: Ding, Peng, et al.
Publicado: (2017)

Peripheral T-cell Lymphoma-Unspecified (PTCL-U) Presenting with Hypereosinophilic Syndrome and Pleural Effusions
por: Choi, Won, et al.
Publicado: (2006)

Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice
por: Haney, Staci L., et al.
Publicado: (2016)

The cardiac chemoreflex sensitivity (cCRS) and the influence of respiration
por: Schmidt, BH, et al.
Publicado: (1999)

Macrophage, the potential key mediator in CAR-T related CRS
por: Hao, Zhaonian, et al.
Publicado: (2020)

CRS-Risiko, COVID-19-Impfung und Checkpointhemmung
por: Borchers, Moritz
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8gac9756df8ffsnadbofar0th9